Celerion Vaccine Development. Global Access. Local Expertise. Learn More

Platforms & Performance


Gene therapy

Celerion’s rapidly expanding gene therapy focus supports our clients’ bioanalytical needs for drug development by utilizing our international laboratories and top-fight scientists


The Evolving Role of Gene Therapy in Drug Development


Gene therapy medicinal products (GTMPs) generally consist of a vector or delivery formulation/ system with an expressed therapeutic sequence including a genetic construct expressing therapeutic sequence or protein used to therapeutically target a genetic sequence for regulation, repair, addition or deletion.


Gene Therapy Product Support for

  • siRNA, RNA and DNA and Oligos
  • Encapsulated and naked plasmids and mRNAs
  • Viral vectors (adenovirus vectors (AdVs), adeno-associated virus vectors (AAVs), baculoviral vectors (BVs) and lentivirus vectors (LV))

Bioanalytical Strategy for Gene Therapy Product Development

celerion-gene-therapy-instrumentation

Gene Therapy


Biomarkers for Immuno-Oncology

View White Paper

Gene Therapy


Unlocking the Value of Flow Cytometry

View White Paper